(Q38055210)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094822%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Histone deacetylase inhibitors: a patent review (2009 - 2011) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094822%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094822%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Marco Miceli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094822%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Lucia Altucci

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094822%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Angela Nebbioso

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094822%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Marco Miceli

2

1 reference

27 August 2017

language of work or name

English

0 references

publication date

25 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094822%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Therapeutic Patents

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094822%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094822%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094822%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

1-17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094822%20AND%20SRC:MED&resulttype=core&format=json

Rules for making human tumor cells

16 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Epigenetics and microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

21 January 2018

The mammalian epigenome

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

The language of covalent histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Translating the Histone Code

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Histone acetylation and chromatin signature in stem cell identity and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Histone modifications: signalling receptors and potential elements of a heritable epigenetic code

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Histone acetylation and deacetylation in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Mutagenesis of pairwise combinations of histone amino-terminal tails reveals functional redundancy in budding yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Worms gang up on bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

The history of cancer epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Linking the epigenetic 'language' of covalent histone modifications to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

A tale of histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Epigenetics: a landscape takes shape

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Repression by Ume6 involves recruitment of a complex containing Sin3 corepressor and Rpd3 histone deacetylase to target promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Roles of histone acetyltransferases and deacetylases in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Histone acetylation in chromatin structure and transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Covalent modifications of histones: expression from chromatin templates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Control of histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Acetylation of histones and transcription-related factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Histone deacetylases (HDACs): characterization of the classical HDAC family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

The human histone deacetylase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Sirtuins and disease: the road ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Structure of the histone deacetylase SIRT2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Histone deacetylases specifically down-regulate p53-dependent gene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Acetylation of general transcription factors by histone acetyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Regulation of activity of the transcription factor GATA-1 by acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Histone deacetylases, transcriptional control, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Histone acetylation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Targeting epigenetic readers in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Histone deacetylase inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Non-invasive tests in animal models and humans: a new paradigm for assessing efficacy of biologics including prebiotics and probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Structural origin of selectivity in class II-selective histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Histone deacetylase inhibitors in cancer therapy: new compounds and clinical update of benzamide-type agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Huntington's disease and HDACi: would sulpiride and valproate be of therapeutic value?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Identification of novel isoform-selective inhibitors within class I histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Rational combinations using HDAC inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Genomics and cancer drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Nuclear structure and the microdistribution of radiation damage in DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Heterogeneity of radiation response of a parent human epidermoid carcinoma cell line and four clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

HDAC inhibitor-mediated radiosensitization in human carcinoma cells: a general phenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

"Stemness": transcriptional profiling of embryonic and adult stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

A stem cell molecular signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Hematopoietic cytokines, transcription factors and lineage commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Histone deacetylase inhibitors in cell pluripotency, differentiation, and reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

H3K9 histone acetylation predicts pluripotency and reprogramming capacity of ES cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

21 January 2018

Human cardiac stem cells

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Global histone H4 acetylation and HDAC2 expression in colon adenoma and carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Immunohistochemical detection of histone deacetylases in endometrial carcinoma: involvement of histone deacetylase 2 in the proliferation of endometrial carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Molecular and pharmacological aspects of antiestrogen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Mechanisms of tamoxifen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers--role of estrogen receptor and HER2 reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Recent understanding of the molecular mechanisms for the efficacy and resistance of EGF receptor-specific tyrosine kinase inhibitors in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Recent developments of small molecule EGFR inhibitors based on the quinazoline core scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Role of DNA methyltransferases in regulation of human ribosomal RNA gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493

Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736493